CatalystWireBeta

Mcbride (MCB): Middle East input cost inflation

This situation live

MCB Mcbride

£304m · 180.2p · +34% since the first step
206.0p 135.0p Now 180.2p · 23 Oct −3% +38% −8% Mar ’26AprMayJunJulAugSepOct
15 Sep 2026 · Q4 FY26 hit absorbed; Q1 FY27 lag expected · −8% since The Group currently expects margins to normalise from the second quarter of the 2027 financial year.
Upgrade / downgrade cycle
Middle East input cost inflation
Q4 FY26 hit absorbed; Q1 FY27 lag expected
Next: margins to normalise from Q2 FY27, subject to materials pricing
Every step · 3
  1. 2 Apr 2026 Elevated costs from April; surcharges notified – Consequently, the Group has already informed all customers about temporary price adjustments, or surcharges to current pricing, to recover these higher,... ↗
  2. 12 Jun 2026 Costs above expectations; second price recovery phase – The cumulative impact on input costs has exceeded our original expectations due to the continuing and prolonged period of the conflict, which has required a... ↗
  3. 15 Sep 2026 Q4 FY26 hit absorbed; Q1 FY27 lag expected – The Group currently expects margins to normalise from the second quarter of the 2027 financial year. ↗

What is happening

Mcbride: Middle East input cost inflation – Q4 FY26 hit absorbed; Q1 FY27 lag expected. ['Q4 FY26 hit absorbed; Q1 FY27 lag expected']

In short
From April 2026 the Middle East conflict raised petrochemical, energy, packaging and haulage costs. On 12 Jun 2026 FY26 and FY27 adjusted EBITA was guided 5-10% below consensus. FY26 results on 15 Sep 2026 show adjusted operating profit of £59.0m (2025: £66.1m) on the Q4 margin lag. Further price rises are increasingly likely and Q1 FY27 lag is expected.
Announced
2 Apr 2026 · Elevated costs from April; surcharges notified
Latest
15 Sep 2026 · Q4 FY26 hit absorbed; Q1 FY27 lag expected
Consensus
FY26 £64.2m; FY27 £70.6m (Group-compiled adjusted EBITA)
Timing of impact
Concentrated in Q4 FY26 and Q1 FY27
Exposure
Limited to less than a full 3-month cost impact
Recovery
Three-month pricing approach; further price rises increasingly likely
Normalisation
Back on track for FY27 heading into Q2 FY27 and beyond
FY26 result
Adjusted operating profit £59.0m vs £66.1m; adjusted EBITDA margin 8.6% vs 9.3%
Timing
Impact in Q4 FY26 and early FY27; margins to normalise from Q2 FY27
Net debt
£122.8m, 1.5x adjusted EBITDA (2025: 1.2x)

What comes next

margins to normalise from Q2 FY27, subject to materials pricing.

Briefing Pro

New to Mcbride? Get up to speed in 2 minutes.

What it does, how it got here, what management promised and delivered – written from its own announcements.

Get the MCB briefing →
Ask MCB Beta
Ask anything about Mcbride

Answered from its own announcements and reported figures, every statement linked to its source.

From the company's own announcements. Not investment advice.

Also at Mcbride 2 open
Transformational contract / build-outVestacy contract manufacturing partnership – SPA signed; completion expected early 2027 Capital returnSpecial dividend and buyback programme – proposed Insider conviction6 directors buying – £480k in 9 buys · closed Mcbride – company page →

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note